Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancerTomohiro Kaku, Akihiro Tasaka, Takenori Hitaka et al.|Bioorganic & Medicinal Chemistry|2011Cited by 126
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeysMasuo Yamaoka, Masami Kusaka, Takahito Hara et al.|The Journal of Steroid Biochemistry and Molecular Biology|2012Cited by 116
C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitorsNobuyuki Matsunaga, Akihiro Tasaka, Tomohiro Kaku et al.|Bioorganic & Medicinal Chemistry|2004Cited by 56
C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitorsNobuyuki Matsunaga, Akihiro Tasaka, Toshimasa Tanaka et al.|Bioorganic & Medicinal Chemistry|2004Cited by 40
Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male ratsTakahito Hara, Masuo Yamaoka, Jin Kouno et al.|The Journal of Steroid Biochemistry and Molecular Biology|2012Cited by 31